Polidocanol foam with or without transdermal Nd:YAG 1064 nm laser for lower‑leg varicose veins
Official title: Comparação da eficácia clínica e estética Entre o Tratamento de Varizes Com Espuma de Polidocanol Associada ou não ao Laser transdérmico: Ensaio clínico Randomizado
Run by Hospital Universitario Pedro Ernesto · NCT07276243 · Data updated 2026-11-12
This trial will test whether adding a transdermal Nd:YAG 1064 nm laser to polidocanol foam sclerotherapy helps close and improve the appearance of lower‑leg varicose veins in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 75 Years |
| Sex | All |
| Enrollment | 102 (estimated) |
| Sponsor | Hospital Universitario Pedro Ernesto Academic / other |
| Locations | 1 site (Rio de Janeiro, Rio de Janeiro) |
| Status | Recruiting |
| Started | March 24, 2026 |
| Main results expected | August 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT07276243 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 21–75 years with CEAP clinical class 1–3 lower‑limb tributary varicose veins measuring 2.5–4.0 mm on Doppler, vein depth ≤4 mm, competent saphenous vein, BMI <35, and able to give informed consent.
✕Probably not a fit
Patients with CEAP ≥4, axial reflux requiring prior treatment, tributary veins outside the 2.5–4.0 mm or >4 mm depth criteria, pregnancy or breastfeeding, known polidocanol allergy, recent DVT/PE, uninterruptible anticoagulation, or active skin infection are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, parallel study with blinded outcome assessment comparing polidocanol foam alone to polidocanol foam plus transdermal 1064 nm Nd:YAG laser for lower‑limb tributary varicose veins. After 1:1 randomization, the control arm receives 0.5% polidocanol foam and the intervention arm receives 0.25% polidocanol foam followed by transdermal laser application; a second session is allowed at 30 days if partial occlusion persists. The primary endpoint is venous occlusion at 30 days measured by Doppler ultrasound, with additional follow‑ups and assessments at 30, 90, and 180 days for pigmentation, pain, patient satisfaction, number of sessions, and adverse events. Standardized photographs are taken at baseline and each follow‑up to document aesthetic outcomes.
Why it matters
Potential benefit: If successful, adding the laser could increase early vein closure and improve cosmetic results, potentially reducing the need for repeat treatments.
How similar studies have gone: Foam sclerotherapy and Nd:YAG lasers have shown benefit separately in prior work, but the specific combination of transdermal Nd:YAG with lower‑concentration polidocanol foam is relatively novel and has limited published evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 21 to 75 years * CEAP clinical class 1-3 * Lower limb tributary varicose veins 2,5 to 4,0 mm in diameter on Doppler ultrasound. * Vein depth up to 4 mm from the skin surface. * Tributary vein may originate from the great or small saphenous vein as long as the saphenous vein is competent on Doppler. * Reflux limited to the target tributary. * Body mass index (BMI) \< 35 km²/m² * Able and willing to provide informed consent. Exclusion Criteria: * CEAP clinical class ≥ 4 * Axial reflux of the great or small saphenous vein requiring prior treatment * Tributary vein diameter \< 2.5 mm or \> 4.0 mm on Doppler * Tributary vein depth \> 4 mm from the skin surface * Pregnancy or breastfeeding * Known allergy or hypersensitivity to polidocanol * History of deep vein thrombosis or pulmonary embolism in the last 6 months * Use of anticoagulant therapy that cannot be safely interrupted * Active skin infection or ulcer at the treatment site * Autoimmune or connective tissue disease with active vasculitis * BMI ≥ 35 kg/m² * Inability to comply with follow-up visits * Previous treatment of the target vein in the past 6 months (laser, foam, surgery, or microphlebectomy).
Where it's running
-
Hospital Universitário Pedro Ernesto - UERJ
Rio de Janeiro, Rio de Janeiro, Brazil Recruiting
Study contacts
- Principal investigator: Juliana Vieira, PhD — Hospital Universitário Pedro Ernesto - UERJ
- Study coordinator: Juliana de Miranda Vieira, PhD
- Email: juliana.vieira@hupe.uerj.br
- Phone: + 55 21 99972 2885
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ITHBC-based nursing program to support self-care after leg varicose vein surgery
This project will try a nursing program based on ITHBC theory to help adults manage their recovery and self-care after surgery for varicose veins in the legs.
-
Laser crossectomy with 1470 nm versus 1940 nm to prevent varicose vein recurrence
This will test whether doing a flush laser crossectomy with either a 1470 nm or 1940 nm laser lowers the chance of varicose vein recurrence and heat-related clots in adults with great saphenous vein reflux.
-
Vacuum-assisted Laser Ablation for large saphenous veins
This study is testing a new method called vacuum-assisted laser ablation to see if it works better and is safer than the traditional method for treating large varicose veins.
-
Preventing blood clots in patients undergoing varicose vein treatment
This study tests different blood-thinning medications to see which one best helps prevent blood clots in adults getting treatment for varicose veins.
-
Comparing two laser wavelengths for treating varicose veins
This study is testing whether using two different laser wavelengths to treat varicose veins can help patients feel better and have fewer complications.
-
Validation of Caprini Score for Patients Undergoing Varicose Vein Surgery
This study is testing if the Caprini score can help identify adults having varicose vein surgery who are at higher risk for blood clots after their procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.